Period:
Draw Mode:
| Volume | 417,991 |
|
|||||
| News | - | ||||||
| Day High | 0.67 | Low High |
|||||
| Day Low | 0.56 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| AcelRX Pharmaceuticals Inc | ACRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0697 | -10.39% | 0.601 | 16:30:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.60 | 0.56 | 0.67 | 0.601 | 0.6707 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,161 | 417,991 | $ 0.6126534 | $ 256,084 | - | 0.55 - 4.86 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:26:57 | 3 | $ 0.6055 | USD |
AcelRX Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 9.82M | 16.34M | - | 1.77M | 42.33M | 2.59 | 0.24 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
AcelRX Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ACRX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.90 | 0.93 | 0.56 | 0.7643533 | 466,751 | -0.299 | -33.22% |
| 1 Month | 1.09 | 1.09 | 0.56 | 0.8469724 | 295,002 | -0.489 | -44.86% |
| 3 Months | 1.09 | 1.38 | 0.56 | 0.9208691 | 267,308 | -0.489 | -44.86% |
| 6 Months | 0.679 | 1.38 | 0.55 | 0.9023833 | 206,129 | -0.078 | -11.49% |
| 1 Year | 4.58 | 4.86 | 0.55 | 2.13 | 259,843 | -3.98 | -86.88% |
| 3 Years | 28.60 | 58.80 | 0.55 | 24.16 | 1,553,486 | -28.00 | -97.9% |
| 5 Years | 92.00 | 101.00 | 0.55 | 36.58 | 1,590,604 | -91.40 | -99.35% |
AcelRX Pharmaceuticals Description
| AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-02 and ARX-03. The majority of its revenue is generated from DSUVIA product sales in the United States. |